Clinical Trials Logo

Normal Body Weight clinical trials

View clinical trials related to Normal Body Weight.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02994420 Completed - Obesity Clinical Trials

Endocrine and Neural Control of Eating in Women

Start date: July 2016
Phase:
Study type: Observational

The purpose of this study is to better understand how female sex hormones influence the food intake in the gut system through the release of satiety hormones as well as through central regulative mechanisms in the brain that subsequently contribute to the control of eating in healthy women at different stages of the ovarian cycle.

NCT ID: NCT02651597 Completed - Normal Body Weight Clinical Trials

A Study of the Effect of Oats on Post Prandial Glucose Response

Start date: April 2016
Phase: N/A
Study type: Interventional

The objectives are to assess the effects of high viscosity vs. medium and low viscosity oat β-glucan on post-prandial glycemic response in healthy adult participants.

NCT ID: NCT02596776 Completed - Metabolic Syndrome Clinical Trials

Cold Induced Changes in White Adipose

Start date: March 2016
Phase: Early Phase 1
Study type: Interventional

An adaptation to a cold environment is a tendency to generate heat within our body. Some of this heat comes from our fat tissue. Although most fat tissue is "white fat", there are pockets deep within the body that are called "brown fat", which are specially adapted to burning fat and making heat. The investigator believes that our white fat, just underneath the surface of our skin, also has this property to burn fat and make heat, although not at the high level of brown fat. This study is to examine this fat-burning property of the white fat under the skin in response to seasons and to cold. Many such studies have been done in mice, but little has been done in humans. There are a number of factors, including age, weight, and medical history, that may make a person eligible or ineligible to participate in this study. Certain medications could make a person ineligible, but if these medications can be safely altered, the individual may become eligible.